As the first GLP-1 RA that can be used orally, semaglutide is able to effectively control blood glucose levels and achieve appetite reduction and weight loss by slowing down gastric emptying through brain regions that regulate appetite and food intake.264 For patients with T2DM, the use of semaglutide has multiple implications. Here, GLP1R is linked to type 2 diabetes mellitus.